Editorial

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Editorial

Contributors to the 2020 China IP Focus have written about a versatile range of issues, providing useful information for anyone with commercial interests in the jurisdiction. Indeed there are many articles in this supplement which will help foreign entities navigate China's IP terrain, including pieces on how right holders can enforce their IP in China, how US and Chinese disclosure practices compare and how to select Chinese language marks (if the applicant owns a trademark in a foreign language and wants to register a Chinese equivalent).

The Red Canned Herbal Tea judgment is highlighted as an important judgment for the intersection between IP and unfair competition law and the risks involved in trademark licensing. The Honda decision is also covered in some depth in this focus. This reversed a previous SPC ruling in the Pretul case. The Honda case deemed affixation of a trademark on a product solely intended for export by an OEM, "use" of a trademark. Both the Red Canned Herbal Tea and Honda judgments were selected as key cases by the SPC.

The articles in this issue of the China IP Focus also deal with other relevant matters, such as the evidence rules in IP litigation and the different defences in a patent infringement claim. We hope, here at Managing IP, that this supplement will be a useful stepping stone to understanding China's IP laws.

Sanjana Kapila

Commercial projects editor

Managing IP

more from across site and SHARED ros bottom lb

More from across our site

New members of the Access Advance patent pool and Harvard University coming under fire were also among the top talking points
Team from Graham Watt & Co will join Beck Greener’s London office
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
In major recent developments, a confidentiality request was rejected, Samsung and its representative A&O Shearman secured a partial win, and EIP made a new hire
Tomas Wässingbo joins us for our ‘Five minutes with’ series to explain why he wants to change the perception around designs
PepsiCo was represented by PwC, while the Australian Taxation Office was advised by Australian-headquartered law firm MinterEllison
The firm said revenue from its ‘refreshed and expanded’ IP team increased by 4% in FY25
Gift this article